Soleno Therapeutics Advances Commercial Strategy for Prader Willi Syndrome Treatment Following Guggenheim Summit
Soleno Therapeutics continues to make significant strides in its mission to address the unmet medical needs of patients living with Prader Willi
by 
Josh Weiner
Josh Weiner